David Steinberg Email & Phone Number

New York, Ny, Us

Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others.

Boston, Ma, Us

Waltham, Ma, Us

Cambridge, Ma, Us

Cambridge, Massachusetts, Us

Be Biopharma (www.be.bio) is a leader in developing B cells as medicines, treating disease with the human body’s native protein factories. We precisely engineer B cells to harness their intrinsic drug-like properties – remarkable protein production, selective tissue targeting, and fine control of their cellular environment – to forge a new category of cell therapy. These medicines are designed to be durable, re-dosable and administered without toxic conditioning, creating new avenues to halt or reverse severe diseases like cancer, autoimmune conditions, and enzyme deficiency. Founded by Longwood Fund and B cell engineering pioneers David Rawlings, MD, and Richard James, PhD, Be Biopharma is re-imagining medicine based on the power of B cell therapy

Boston, Ma, Us

Boston, Ma, Us

San Diego, California, Us

Boston, Ma, Us

Pyxis Oncology (NASDAQ:PYXS) is developing therapeutics to promote the body's immune response to cancer, based on new insights into the tumor microenvironment.www.pyxisoncology.com

Targeting the biology of aging to prevent or treat aging-related diseases

Cambridge, Massachusetts, Us

Vor Biopharma (NASDAQ:VOR) is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.

Cambridge, Ma, Us

Rationally designing medicines based on consortia of human commensal bacteria to treat disease, using insights from microbial ecology, mucosal immunology, and human interventional studies.

Boston, Massachusetts, Us

Co-founder of multiple biotechnology/medtech startups, including four IPOs (VOR, TORC, PRTC, NDRA) valued at over $2B (as of Feb '21) with multiple marketed and clinical stage products including:PureTech Health (PRTC.L), a publicly-traded science-driven healthcare company, that seeks to solve some of today’s toughest health challenges through disruptive approaches.ResTORbio (NASDAQ: TORC) : https: www.restorbio.com -a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases, with lead asset inlicensed from Novartis; co-founded, led series A March '17; $400 M IPO Jan '18Vedanta Biosciences: www.vedantabio.com - a leading clinical-stage microbiome company; led and closed $300M + biodollars partnership with J&J.Vor Biopharma (NASDAQ:VOR): www.vorbiopharma.com - Immuno-oncology company co-founded with Pulitzer Prize winning oncologist Dr. Sid MukherjeeEntrega: www.entregabio.com - for oral delivery of biologics and complex molecules; Partnership with Google Verily, Eli LillyFollica: www.follicabio.com - stem cell-based treatments for hair growth and other dermatological disorders; Phase II clinical trials

Created and launched cross-pharma funding syndicate for platform technologies to transform R&D. Members included Abbott, Lilly, Merck, Pfizer, Novartis, Johnson & Johnson, Novo Nordisk, and AstraZeneca

Boston, Massachusetts, Us

Strategy consultant to multinational pharmaceutical and educational institutions

R&D, product launch and salesforce strategy for Fortune 500 Pharmaceutical companies

Cincinnati, Ohio, Us

Mba, Strategy, Finance

Ba, Biology